The Endocrine and Metabolism PRN Education Committee presents an educational session focused on integrating lifestyle medicine interventions with medication deprescribing in persons with type 2 diabetes (T2D).  The session serves as a practical, comprehensive guide to the effective integration of lifestyle medicine principles with medication deprescribing for improved and sustained clinical outcomes in persons with T2D. Specific topics will include a (1) review of guideline recommendations of specific dietary and other lifestyle interventions for persons with T2D; (2) review of clinical trial evidence and the use of specific dietary interventions for achievement of glycemic targets and related clinical outcomes; and (3) best practices in deprescribing and/or safe pharmacologic management for persons with T2D implementing intensive or specific dietary interventions. The target audience includes pharmacists, residents, fellows, and students with an interest in enhancing their knowledge of effective and safe pharmacologic management in the setting of intensive therapeutic lifestyle changes (ITLC). The primary purpose of this session is to educate and summarize practical insights and tools to integrate evidence-based lifestyle medicine interventions with medication deprescribing, contributing to more comprehensive and personalized T2D management.

Faculty

Moderator: Megan E. Wesling, Pharm.D., BCACP, BCPS